文献速递前列腺癌

前列腺癌根治术中的盆腔淋巴结清扫是否必要:多中心纵向研究评估肿瘤学结局

Pelvic Lymph Node Dissection in Prostate Cancer: Is It Really Necessary? A Multicentric Longitudinal Study Assessing Oncological Outcomes in Patients With Prostate Cancer Undergoing Pelvic Lymph Node Dissection vs Radical Prostatectomy Only.
PubMed 文献 · J Urol · 2025-04-28

该多中心纵向队列研究纳入1996年至2021年间2346例接受根治性前列腺切除术的前列腺癌患者,其中1650例行扩大盆腔淋巴结清扫(PLND),696例未行PLND。

核心结论

  • PLND可改善D'Amico中危和高危前列腺癌患者的无转移生存,可考虑在根治性前列腺切除术中实施。

主要发现

  • 多变量Cox回归中,PSA、ISUP分级组和病理T分期为无转移生存的显著预后因素。

临床怎么用

  • 对于D'Amico中危和高危前列腺癌患者,在根治性前列腺切除术中可考虑行盆腔淋巴结清扫以改善无转移生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: With the availability of prostate-specific membrane antigen positron emission tomography scans, it is controversial whether pelvic lymph node dissection (PLND) at the time of radical prostatectomy (RP) is still the most reliable and accurate staging modality for lymph node assessment. Furthermore, the oncological benefit of PLND remains unclear. The aim of this study was to assess whether omitting PLND in patients undergoing RP for prostate cancer (PCa) is associated with the risk of tumor recurrence and progression to metastasis. MATERIALS AND METHODS: In this longitudinal multicenter cohort study, we reviewed data of 2346 consecutive patients with PCa who underwent RP with (n = 1650) and without (n = 696) extended PLND between January 1996 and December 2021. Recurrence-free survival and metastasis-free survival (MFS) were analyzed as a time-to-event outcome using Kaplan-Meier analyses with log-rank tests. To assess the effect of PLND, we created multivariable Cox proportional hazards models adjusting for relevant clinical and demographic characteristics. RESULTS: Median follow-up was 44 months. There was no difference in recurrence-free survival between men who had a PLND and those who did not (HR, 1.07, 95% CI, 0.87-1.32, P = .52). Patients with D'Amico high-risk disease (PSA >20 µg/L and/or International Society of Urological Pathology grade group ≥4) demonstrated a significantly prolonged MFS if they underwent PLND (HR, 0.57, 95% CI, 0.36-0.91, P = .02). PLND also improved MFS in patients with intermediate-risk disease (HR, 0.48, 95% CI, 0.25-0.90, P = .023). Further significant prognostic variables for MFS on multivariable Cox proportional hazards regression were PSA, International Society of Urological Pathology grade group, and pathological T-stage. CONCLUSIONS: PLND improves MFS in patients with D'Amico intermediate-risk and high-risk PCa and may therefore be considered in men undergoing RP.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Furrer MA, Sathianathen NJ, Mulholland CJ, et al. Pelvic Lymph Node Dissection in Prostate Cancer: Is It Really Necessary? A Multicentric Longitudinal Study Assessing Oncological Outcomes in Patients With Prostate Cancer Undergoing Pelvic Lymph Node Dissection vs Radical Prostatectomy Only. J Urol. 2025. PMID: 40294214. doi:10.1097/JU.0000000000004587

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。